VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1543624
Sex: F
Age:
State: OH

Vax Date: 02/01/2021
Onset Date: 02/02/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling around the injection site; arm soreness; Pain; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), VACCINATION SITE PAIN (Pain), VACCINATION SITE ERYTHEMA (redness around the injection site) and VACCINATION SITE SWELLING (Swelling around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE ERYTHEMA (redness around the injection site). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling around the injection site). At the time of the report, PAIN IN EXTREMITY (arm soreness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.

Other Meds:

Current Illness:

ID: 1543625
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt soreness on his arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Felt soreness on his arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history provided). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Felt soreness on his arm). At the time of the report, VACCINATION SITE PAIN (Felt soreness on his arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant information provided. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543626
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm pain; Tremors where a little stronger; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) and TREMOR (Tremors where a little stronger) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037k20A) for COVID-19 vaccination. Concurrent medical conditions included Parkinson's disease (He has tremors due to Parkinson's disease.). On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain) and TREMOR (Tremors where a little stronger). At the time of the report, PAIN IN EXTREMITY (Arm pain) and TREMOR (Tremors where a little stronger) outcome was unknown. No concomitant medications were provided No treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Parkinson's disease (He has tremors due to Parkinson's disease.)

ID: 1543627
Sex: F
Age: 49
State: NY

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: also a little bit on my right arm and big welts all over my back; felt like something was biting me; Itchy at injection site; these giant welts all over where I got the injection; arm was killing me for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was killing me for 2 days), VACCINATION SITE DYSAESTHESIA (felt like something was biting me), VACCINATION SITE URTICARIA (these giant welts all over where I got the injection), URTICARIA (also a little bit on my right arm and big welts all over my back) and VACCINATION SITE PRURITUS (Itchy at injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. Concurrent medical conditions included Cancer (NOS) (in remission). Concomitant products included PALBOCICLIB (IBRANCE), LETROZOLE and VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for an unknown indication. On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was killing me for 2 days). On 19-Jan-2021, the patient experienced VACCINATION SITE DYSAESTHESIA (felt like something was biting me), VACCINATION SITE URTICARIA (these giant welts all over where I got the injection), URTICARIA (also a little bit on my right arm and big welts all over my back) and VACCINATION SITE PRURITUS (Itchy at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 19-Jan-2021 for Adverse event, at a dose of UNK dosage form (for 2 days). On 12-Jan-2021, PAIN IN EXTREMITY (arm was killing me for 2 days) had resolved. On 22-Jan-2021, VACCINATION SITE URTICARIA (these giant welts all over where I got the injection) and URTICARIA (also a little bit on my right arm and big welts all over my back) had resolved. At the time of the report, VACCINATION SITE DYSAESTHESIA (felt like something was biting me) and VACCINATION SITE PRURITUS (Itchy at injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient was due for her second dose on 07-Feb-2021. The patient took the first doe when she was on her off week of Ibrance. The patient took Ibrance on 18-Jan-2021 and on 19-Jan-2021, the patient developed giant welts all over where she got the injection and also a little bit on her right arm and big welts all over her back. The doctor asked her to stop Ibrance for the time.

Other Meds: IBRANCE; LETROZOLE; EFFEXOR

Current Illness: Cancer (NOS) (in remission)

ID: 1543628
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mouth sores (Ulcers)-area like circle and spots and spots were not bleeding; This spontaneous case was reported by a consumer and describes the occurrence of MOUTH ULCERATION (Mouth sores (Ulcers)-area like circle and spots and spots were not bleeding) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOUTH ULCERATION (Mouth sores (Ulcers)-area like circle and spots and spots were not bleeding). At the time of the report, MOUTH ULCERATION (Mouth sores (Ulcers)-area like circle and spots and spots were not bleeding) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported. Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Updated Email address and address of reporter

Other Meds:

Current Illness:

ID: 1543629
Sex: F
Age: 79
State: FL

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Palms looked like black blue tie dye; Twinge twice in left breast; shoulder pain above injection site; A spontaneous report was received from a consumer concerning a 79-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced shoulder pain above injection site, twinge twice in left breast and palms looked like black blue tie dye. The patient's medical history included lumpectomy and chemotherapy. No relevant concomitant medications were reported. On 22 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (029L20A) intramuscularly in the shoulder for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced shoulder pain above injection site, twinge twice in left breast and palms looked like black blue tie dye. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. On an unknown date, the event palms looked like black blue tie dye was resolved. The outcome of the events shoulder pain above injection site and twinge twice in left breast was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543630
Sex: F
Age: 80
State: FL

Vax Date: 01/15/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot; arm was itching; arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot; arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot), VACCINATION SITE PRURITUS (arm was itching), VACCINATION SITE SWELLING (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot) and VACCINATION SITE ERYTHEMA (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high, Vitamin D deficiency and High cholesterol. Concomitant products included HYDROCHLOROTHIAZIDE, VALSARTAN (DIOVAN HCT) for Blood pressure high, MONASCUS PURPUREUS, UBIDECARENONE (CHOLEAST) for Hypercholesterolaemia, COLECALCIFEROL (VIT D3) for Vitamin D3 deficiency. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE WARMTH (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot), VACCINATION SITE PRURITUS (arm was itching), VACCINATION SITE SWELLING (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot) and VACCINATION SITE ERYTHEMA (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot). The patient was treated with ACETAMINOPHEN for Adverse event, at a dose of 625 milligram and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. On 28-Jan-2021, VACCINATION SITE WARMTH (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot), VACCINATION SITE PRURITUS (arm was itching), VACCINATION SITE SWELLING (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot) and VACCINATION SITE ERYTHEMA (arm was swelling, and developed a bump of 3 inches x 2.5 inches that was red and hot) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. This case was linked to MOD-2021-252963 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Follow up received on 11JUL2021, included reporter's contact details, updated patient's demographics, medical history, 2nd dose was given 12FEB2021 Lot@039K20A and action taken with the drug was updated to no change, concomitant medications, treatment medication (Acetaminophen), events stop date and outcome was updated as recovered.

Other Meds: DIOVAN HCT; VIT D3; CHOLEAST

Current Illness: Blood pressure high; High cholesterol; Vitamin D deficiency

ID: 1543631
Sex: F
Age: 65
State: WV

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Difficulty breathing; Growling sensation in chest; Heart palpitations; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Growling sensation in chest) and PALPITATIONS (Heart palpitations) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included Chemical injury (Toxic Injury from her previous employment) in 1999. Concurrent medical conditions included Sleep apnea (previous medical history). Concomitant products included VITAMIN E NOS and CALCIUM for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced FATIGUE (Fatigue), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Growling sensation in chest) and PALPITATIONS (Heart palpitations). The patient was treated with VITAMIN D [VITAMIN D NOS] ongoing since an unknown date at a dose of UNK dosage form and CLONIDINE in February 2021 for Adverse event, at a dose of UNK dosage form. On 06-Feb-2021, FATIGUE (Fatigue), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Growling sensation in chest) and PALPITATIONS (Heart palpitations) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Blood pressure measurement: high (High) high. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient was using CPAPA machine. The patient reported that those symptoms caused her to go to the Emergency Room on 05-FEB-2021.

Other Meds: VITAMIN E NOS; CALCIUM

Current Illness: Sleep apnea (previous medical history)

ID: 1543632
Sex: F
Age: 47
State: GA

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: develop rash at injection site; rash spread to chest and throat at 12 noon and then all over body including thigh; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash spread to chest and throat at 12 noon and then all over body including thigh) and VACCINATION SITE RASH (develop rash at injection site) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L30N) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced RASH (rash spread to chest and throat at 12 noon and then all over body including thigh). On 22-Jan-2021 at 10:15 AM, the patient experienced VACCINATION SITE RASH (develop rash at injection site). At the time of the report, RASH (rash spread to chest and throat at 12 noon and then all over body including thigh) and VACCINATION SITE RASH (develop rash at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543633
Sex: F
Age: 53
State: MD

Vax Date: 01/08/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hive is back, horseshoe shaped, red and very itchy; Painful at the injection site; low grade fever; Headache; Achy; Stomach upset; hot to touch at the inejction site; Hive at the injection site then 10 more showed up; 3x5 inch raised and itchy; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE URTICARIA (Hive at the injection site then 10 more showed up; 3x5 inch raised and itchy), VACCINATION SITE PAIN (Painful at the injection site), PYREXIA (low grade fever), HEADACHE (Headache) and ABDOMINAL DISCOMFORT (Stomach upset) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for covid-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient had no drug allergies or any medical history. Concurrent medical conditions included Allergic reaction to bee sting. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Hive at the injection site then 10 more showed up; 3x5 inch raised and itchy). On 16-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to touch at the inejction site). On 18-Jan-2021, the patient experienced VACCINATION SITE PAIN (Painful at the injection site), PYREXIA (low grade fever), HEADACHE (Headache), ABDOMINAL DISCOMFORT (Stomach upset) and MYALGIA (Achy). On 21-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (hive is back, horseshoe shaped, red and very itchy). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) in January 2021 for Adverse event, at a dose of UNK dosage form; CORTISONE (topical) in January 2021 for Adverse event, at a dose of UNK dosage form, tid; FAMOTIDINE (PEPCID [FAMOTIDINE]) in January 2021 for Adverse event, at a dose of UNK dosage form (for a week); DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in January 2021 for Adverse event, at a dose of UNK dosage form (for a week); LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) in January 2021 for Adverse event, at a dose of UNK dosage form (for a week) and IBUPROFEN in January 2021 for Adverse event, at a dose of 600 mg. On 20-Jan-2021, VACCINATION SITE URTICARIA (Hive at the injection site then 10 more showed up; 3x5 inch raised and itchy), VACCINATION SITE PAIN (Painful at the injection site), PYREXIA (low grade fever), HEADACHE (Headache), ABDOMINAL DISCOMFORT (Stomach upset), VACCINATION SITE WARMTH (hot to touch at the inejction site) and MYALGIA (Achy) had resolved. At the time of the report, VACCINATION SITE URTICARIA (hive is back, horseshoe shaped, red and very itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. The patient used Pepcid, Benadryl, and xyzal for a week and it was pretty much gone by Wednesday. The patient stopped taking antihistamine because allergist would not see her if she did not stop using antihistamines and hive was back, horseshoe shaped, red and very itchy. The patient had scheduled an appointment with doctor on Monday.

Other Meds:

Current Illness: Allergic reaction to bee sting

ID: 1543634
Sex: F
Age: 69
State: TX

Vax Date: 01/14/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history per source document.). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching). At the time of the report, VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (itching) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543635
Sex: F
Age: 81
State: AL

Vax Date: 01/14/2021
Onset Date: 01/23/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching; RASH; plushed face; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching), RASH (RASH) and FLUSHING (plushed face) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The patient's past medical history included Hypothyroidism, GERD, Osteopenia, Vitamin D deficiency and Vitamin B12 deficiency. Concomitant products included OMEPRAZOLE for GERD, VITAMINS NOS and LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, IBUPROFEN from 25-Mar-2021 to an unknown date for Knee pain, CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]) for Vitamin B12 deficiency. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PRURITUS (itching), RASH (RASH) and FLUSHING (plushed face). The patient was treated with CALCIUM ongoing since an unknown date for Osteopenia, at a dose of 500 UNK, qd. At the time of the report, PRURITUS (itching), RASH (RASH) and FLUSHING (plushed face) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. no treatment provided

Other Meds: VITAMINS NOS; IBUPROFEN; OMEPRAZOLE; SYNTHROID; VITAMIN B 12 [CYANOCOBALAMIN]

Current Illness:

ID: 1543636
Sex: F
Age: 91
State: FL

Vax Date: 01/14/2021
Onset Date: 01/24/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash on injection site that was itchy and red; rash on injection site that was itchy and red; rash on injection site that was itchy and red; the infection site was warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on injection site that was itchy and red), VACCINATION SITE PRURITUS (rash on injection site that was itchy and red), VACCINATION SITE ERYTHEMA (rash on injection site that was itchy and red) and VACCINATION SITE WARMTH (the infection site was warm to touch) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L208) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history provided). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN) for an unknown indication. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE RASH (rash on injection site that was itchy and red), VACCINATION SITE PRURITUS (rash on injection site that was itchy and red), VACCINATION SITE ERYTHEMA (rash on injection site that was itchy and red) and VACCINATION SITE WARMTH (the infection site was warm to touch). At the time of the report, VACCINATION SITE RASH (rash on injection site that was itchy and red), VACCINATION SITE PRURITUS (rash on injection site that was itchy and red), VACCINATION SITE ERYTHEMA (rash on injection site that was itchy and red) and VACCINATION SITE WARMTH (the infection site was warm to touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. no treatment was given This case was linked to MOD-2021-081188 (Patient Link).

Other Meds: ASPIRIN

Current Illness:

ID: 1543637
Sex: F
Age: 40
State: KY

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: General achiness; Pain at Injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (General achiness), VACCINATION SITE PAIN (Pain at Injection site) and HEADACHE (Headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. Concurrent medical conditions included Migraine. On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN (General achiness), VACCINATION SITE PAIN (Pain at Injection site) and HEADACHE (Headache). At the time of the report, PAIN (General achiness), VACCINATION SITE PAIN (Pain at Injection site) and HEADACHE (Headache) outcome was unknown. Not Provided Concomitant medication details has provided as patient was receiving migraine tablets and allergic medication not specially mentioned the class of drugs; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded

Other Meds:

Current Illness:

ID: 1543638
Sex: F
Age: 87
State: FL

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K209) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up information received on 30-JUN-2021. No new information.

Other Meds:

Current Illness:

ID: 1543639
Sex: F
Age: 62
State: HI

Vax Date: 12/30/2020
Onset Date: 01/06/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching at the injection site; Injection site swelling; The injection site had huge amount of redness; Injection site was hot/ the localized reaction warm to touch; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE ERYTHEMA (The injection site had huge amount of redness), VACCINATION SITE WARMTH (Injection site was hot/ the localized reaction warm to touch) and VACCINATION SITE PRURITUS (Itching at the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history). On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 06-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE ERYTHEMA (The injection site had huge amount of redness) and VACCINATION SITE WARMTH (Injection site was hot/ the localized reaction warm to touch). On 22-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site). The patient was treated with LORATADINE for Itching, Swelling and Rash, at an unspecified dose and frequency and IBUPROFEN for Redness and Swelling, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE ERYTHEMA (The injection site had huge amount of redness), VACCINATION SITE WARMTH (Injection site was hot/ the localized reaction warm to touch) and VACCINATION SITE PRURITUS (Itching at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. no concomitant medication patient used ice packs as his arm was hot at injection site

Other Meds:

Current Illness:

ID: 1543640
Sex: F
Age: 42
State: OH

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site is swollen, red, and warm to the touch; the lymph node on the same side where I had the injection is swollen; hands and arm were tingling; hands and arms were numb; injection site is swollen, red, and warm to the touch; injection site is swollen; hard knot in my arm that has been here for over a week now; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (injection site is swollen, red, and warm to the touch), LYMPHADENOPATHY (the lymph node on the same side where I had the injection is swollen), PARAESTHESIA (hands and arm were tingling), HYPOAESTHESIA (hands and arms were numb) and VACCINATION SITE ERYTHEMA (injection site is swollen, red, and warm to the touch) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no medical history). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (injection site is swollen, red, and warm to the touch), LYMPHADENOPATHY (the lymph node on the same side where I had the injection is swollen), PARAESTHESIA (hands and arm were tingling), HYPOAESTHESIA (hands and arms were numb), VACCINATION SITE ERYTHEMA (injection site is swollen, red, and warm to the touch), VACCINATION SITE SWELLING (injection site is swollen) and INJECTION SITE INDURATION (hard knot in my arm that has been here for over a week now). At the time of the report, VACCINATION SITE WARMTH (injection site is swollen, red, and warm to the touch), LYMPHADENOPATHY (the lymph node on the same side where I had the injection is swollen), PARAESTHESIA (hands and arm were tingling), HYPOAESTHESIA (hands and arms were numb), VACCINATION SITE ERYTHEMA (injection site is swollen, red, and warm to the touch), VACCINATION SITE SWELLING (injection site is swollen) and INJECTION SITE INDURATION (hard knot in my arm that has been here for over a week now) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications and treatment information were not provided. Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: Additional events were provided.

Other Meds:

Current Illness:

ID: 1543641
Sex: M
Age: 43
State: UT

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Exhaustion; Fever 101.8 Fahrenheit; body aches; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Exhaustion), PYREXIA (Fever 101.8 Fahrenheit) and MYALGIA (body aches) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021 at 7:30 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (Exhaustion), PYREXIA (Fever 101.8 Fahrenheit) and MYALGIA (body aches). At the time of the report, FATIGUE (Exhaustion), PYREXIA (Fever 101.8 Fahrenheit) and MYALGIA (body aches) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 101.8 Fahrenheit. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543642
Sex: F
Age: 48
State: NM

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingling on the left side of my face; slight tightness in my throat; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on the left side of my face) and THROAT TIGHTNESS (slight tightness in my throat) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced PARAESTHESIA (Tingling on the left side of my face) and THROAT TIGHTNESS (slight tightness in my throat). At the time of the report, PARAESTHESIA (Tingling on the left side of my face) and THROAT TIGHTNESS (slight tightness in my throat) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1543643
Sex: F
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not provided. no treatment taken

Other Meds:

Current Illness:

ID: 1543644
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Night sweats; Local reactions; Other side effects; Fatigue; Chills/Shaking chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore arm), NIGHT SWEATS (Night sweats), VACCINATION SITE REACTION (Local reactions), VACCINATION COMPLICATION (Other side effects) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no medical history). On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), NIGHT SWEATS (Night sweats), VACCINATION SITE REACTION (Local reactions), VACCINATION COMPLICATION (Other side effects), FATIGUE (Fatigue) and CHILLS (Chills/Shaking chills). At the time of the report, PAIN IN EXTREMITY (Sore arm), NIGHT SWEATS (Night sweats), VACCINATION SITE REACTION (Local reactions), VACCINATION COMPLICATION (Other side effects), FATIGUE (Fatigue) and CHILLS (Chills/Shaking chills) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1543645
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Halo pink sore; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (Halo pink sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Halo pink sore). At the time of the report, VACCINATION SITE ERYTHEMA (Halo pink sore) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. The patient took Benadryl as treatment for their symptoms. This case was linked to MOD-2021-013030 (Patient Link).

Other Meds:

Current Illness:

ID: 1543646
Sex: F
Age: 67
State: TX

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt Weak; Diarrhea; Back ache; Shivers; Fever; Injection site pain; Vomiting; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (Felt Weak), DIARRHOEA (Diarrhea), BACK PAIN (Back ache), CHILLS (Shivers) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ASTHENIA (Felt Weak), DIARRHOEA (Diarrhea), BACK PAIN (Back ache), CHILLS (Shivers), PYREXIA (Fever), VACCINATION SITE PAIN (Injection site pain) and VOMITING (Vomiting). On 22-Jan-2021, ASTHENIA (Felt Weak), DIARRHOEA (Diarrhea), BACK PAIN (Back ache), CHILLS (Shivers), PYREXIA (Fever), VACCINATION SITE PAIN (Injection site pain) and VOMITING (Vomiting) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient took Aspirin on 21-JAN-2021 for treatment of the symptoms.

Other Meds:

Current Illness:

ID: 1543647
Sex: F
Age: 76
State: CA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had metallic taste in mouth; where they gave the vaccine was really painful; This spontaneous case was reported by a patient and describes the occurrence of DYSGEUSIA (had metallic taste in mouth) and VACCINATION SITE PAIN (where they gave the vaccine was really painful) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. Concurrent medical conditions included Gastroenteritis. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DYSGEUSIA (had metallic taste in mouth) and VACCINATION SITE PAIN (where they gave the vaccine was really painful). On 20-Jan-2021, DYSGEUSIA (had metallic taste in mouth) had resolved. On 22-Jan-2021, VACCINATION SITE PAIN (where they gave the vaccine was really painful) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient's concomitant medications included an unspecified medication used for gastroenteritis. The patient used ice for treatment of the vaccination site pain.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Gastroenteritis

ID: 1543648
Sex: F
Age: 46
State: FL

Vax Date: 01/06/2021
Onset Date: 01/10/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tenderness in the arm is not resolving; Swollen; Prolonged swelling of the lymph nodes in the vaccination arm; Chills; body aches; fever; This spontaneous case was reported by a nurse and describes the occurrence of LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm), CHILLS (Chills), MYALGIA (body aches), PYREXIA (fever) and VACCINATION SITE PAIN (tenderness in the arm is not resolving) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm). On an unknown date, the patient experienced CHILLS (Chills), MYALGIA (body aches), PYREXIA (fever), VACCINATION SITE PAIN (tenderness in the arm is not resolving) and VACCINATION SITE SWELLING (Swollen). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm), VACCINATION SITE PAIN (tenderness in the arm is not resolving) and VACCINATION SITE SWELLING (Swollen) had not resolved and CHILLS (Chills), MYALGIA (body aches) and PYREXIA (fever) had resolved. Related The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No laboratory details was given. Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow up contain no new information please to confirm NNI

Other Meds: VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1543649
Sex: F
Age: 27
State: NY

Vax Date: 01/12/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed the Covid virus; cough; trouble breathing; Itchy; Sneezing; Runny nose; Diarrhea; 100.4 fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy) and SNEEZING (Sneezing) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), DIARRHOEA (Diarrhea) and PYREXIA (100.4 fever). On 17-Jan-2021, PYREXIA (100.4 fever) had resolved. At the time of the report, COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and DIARRHOEA (Diarrhea) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Body temperature: 100.4 (High) for two days over the weekend. On 16-Jan-2021, Oxygen saturation: 98-100 normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient's concomitant medications included an unspecified birth control pill. The patient took Allegra and Motrin for treatment of the events.

Other Meds:

Current Illness:

ID: 1543650
Sex: F
Age: 38
State: NY

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant), LETHARGY (lethargy), HYPERSOMNIA (Felt very sleepy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site) in a 38-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 23-Dec-2020 and the estimated date of delivery was 29-Sep-2021. On 11-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On an unknown date, the patient experienced LETHARGY (lethargy), HYPERSOMNIA (Felt very sleepy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the second week of the pregnancy. On 11-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, LETHARGY (lethargy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site) outcome was unknown and HYPERSOMNIA (Felt very sleepy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound foetal: heartbeats detected (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. The patient took Tylenol for the treatment of the events. Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: Updated IRD for the case.

Other Meds:

Current Illness:

ID: 1543651
Sex: F
Age: 70
State: GA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Weak; Real tired and sleepy/exhausted; I could hardly breathe; Dizzy; This spontaneous case was reported by a patient and describes the occurrence of in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The patient's past medical history included Asthma (Patient has a history of asthma but not had asthma or breathing problems since1987 due to keeping it under control). On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form as required. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Treatment information also mentioned an inhaler for treatment of the events. Patient mentioned having a prior anaphylactic shock from an allergy shot much before and was cautious with this vaccine due to that. Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional information added on 25JUN2021 is non significant. Patient updated email ID.

Other Meds:

Current Illness:

ID: 1543652
Sex: M
Age: 71
State: MO

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: anxious; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (anxious) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANXIETY (anxious). At the time of the report, ANXIETY (anxious) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient's concomitant medications included unspecified medication for diabetes. No treatment information was provided.

Other Meds:

Current Illness: Diabetes

ID: 1543653
Sex: M
Age:
State: MI

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Weakness; Dizziness; anxious; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness) and ANXIETY (anxious) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COPD, Emphysema and Reye's syndrome. Previously administered products included for Product used for unknown indication: Flu shot (Previously he had worse reaction to Flu shot). Past adverse reactions to the above products included Adverse reaction with Flu shot. On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness) and ANXIETY (anxious). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness) and ANXIETY (anxious) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1543654
Sex: F
Age: 30
State: VA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Since having my vaccine I have developed a horrible; Pregnant; This spontaneous retrospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and MALAISE (Since having my vaccine I have developed a horrible) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No medical history was provided. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-May-2020 and the estimated date of delivery was 25-Feb-2021. On 19-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 30-May-2021, the patient experienced MALAISE (Since having my vaccine I have developed a horrible). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-seventh week of the pregnancy. The delivery occurred on 29-Jan-2021, which was reported as Full-term. For neonate 1, The outcome was reported as Delivered NOS. On 19-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, MALAISE (Since having my vaccine I have developed a horrible) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2020, Pregnancy test: positive (Positive) Positive. In November 2020, Glucose tolerance test normal: (normal) Normal. In November 2020, Ultrasound abdomen: normal (normal) Normal. In December 2020, Glucose tolerance test normal: (normal) Normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: Follow-up information received on 31-may-2021. Added a event,Since having my vaccine I have developed a horrible.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1543655
Sex: F
Age: 78
State:

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: half of the upper arm was red; slightly elevated skin; arm that got the injection started itching; delayed skin rash at the injection site; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (half of the upper arm was red), VACCINATION SITE SWELLING (slightly elevated skin), VACCINATION SITE PRURITUS (arm that got the injection started itching) and VACCINATION SITE RASH (delayed skin rash at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Allergy to sween cream) and Penicillin allergy. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (half of the upper arm was red), VACCINATION SITE SWELLING (slightly elevated skin), VACCINATION SITE PRURITUS (arm that got the injection started itching) and VACCINATION SITE RASH (delayed skin rash at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (half of the upper arm was red), VACCINATION SITE SWELLING (slightly elevated skin), VACCINATION SITE PRURITUS (arm that got the injection started itching) and VACCINATION SITE RASH (delayed skin rash at the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-077736 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI On 25-May-2021: NNI; Sender's Comments: Based on the current available information and the temporal association between the use of the product and the start date of the event, a casual relationship cannot be excluded.

Other Meds:

Current Illness: Drug allergy (Allergy to sween cream); Penicillin allergy

ID: 1543656
Sex: F
Age: 84
State: TX

Vax Date: 12/29/2020
Onset Date: 01/10/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: infected with COVID 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (infected with COVID 19) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037L20A) for COVID-19 vaccination. No Medical History information was reported. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced COVID-19 (infected with COVID 19). At the time of the report, COVID-19 (infected with COVID 19) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not provided by the reporter. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Significant follow up received - Patient demographics, suspect product details and event details were updated.

Other Meds:

Current Illness:

ID: 1543657
Sex: F
Age:
State: PA

Vax Date: 12/28/2020
Onset Date: 01/06/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She became symptomatic for covid 1/8/21 and tested positive 1/11/21.; Slight occasional cough; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (She became symptomatic for covid 1/8/21 and tested positive 1/11/21.) and COUGH (Slight occasional cough) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included DVT of calf (~35 years ago). Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL and VERAPAMIL HYDROCHLORIDE (CALAN [VERAPAMIL HYDROCHLORIDE]) for an unknown indication. On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced COUGH (Slight occasional cough). On 11-Jan-2021, the patient experienced COVID-19 (She became symptomatic for covid 1/8/21 and tested positive 1/11/21.). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE (DELSYM) for COVID-19 and Cough, at a dose of UNK dosage form. At the time of the report, COVID-19 (She became symptomatic for covid 1/8/21 and tested positive 1/11/21.) and COUGH (Slight occasional cough) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, SARS-CoV-2 test: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient is improving well so far, and is afebrile.

Other Meds: METOPROLOL; CALAN [VERAPAMIL HYDROCHLORIDE]

Current Illness: Hypertension

ID: 1543658
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 12/31/2020
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: infected with COVID 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (infected with COVID 19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 31-Dec-2020, the patient experienced COVID-19 (infected with COVID 19). At the time of the report, COVID-19 (infected with COVID 19) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.

Other Meds:

Current Illness:

ID: 1543659
Sex: F
Age: 71
State:

Vax Date: 01/14/2021
Onset Date: 01/18/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sinus infection; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form; DOXYCYCLINE on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form; MONTELUKAST on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form and ATORVASTATIN CALCIUM (AVASTIN [ATORVASTATIN CALCIUM]) (nasal) on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. This case was linked to MOD-2021-012744 (Patient Link).

Other Meds:

Current Illness:

ID: 1543660
Sex: F
Age: 68
State: TX

Vax Date: 01/14/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm hurting; hard at the injection stie; hurt under her arm; arm red at the injection site; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm hurting), VACCINATION SITE INDURATION (hard at the injection stie), AXILLARY PAIN (hurt under her arm) and VACCINATION SITE ERYTHEMA (arm red at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hard at the injection stie), AXILLARY PAIN (hurt under her arm) and VACCINATION SITE ERYTHEMA (arm red at the injection site). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurting). At the time of the report, PAIN IN EXTREMITY (Arm hurting), VACCINATION SITE INDURATION (hard at the injection stie), AXILLARY PAIN (hurt under her arm) and VACCINATION SITE ERYTHEMA (arm red at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1543661
Sex: M
Age: 45
State: PA

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Can't eat anything; Anxious; dizziness; Nauseous; fever; diarrhea; Achiness all over body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and PAIN (Achiness all over body) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever). On 17-Jan-2021, the patient experienced EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous). On 15-Jan-2021, DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever) had resolved. At the time of the report, EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1543662
Sex: F
Age: 75
State: WA

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash all over my back; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rash all over my back) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced RASH (Rash all over my back). On 17-Jan-2021, RASH (Rash all over my back) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1543663
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stiff neck; baseball size lump; hard, hot, red baseball size lump; Itching at the site; red baseball size lump; hot; Arm mildly sore; Neck pain; Back pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot) and MUSCULOSKELETAL STIFFNESS (Stiff neck) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Chronic back pain and Neck pain. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain) and BACK PAIN (Back pain). On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck). At the time of the report, PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-077018 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: The patient details, vaccine information and event outcome were updated.

Other Meds:

Current Illness: Chronic back pain; Neck pain

ID: 1543664
Sex: M
Age: 56
State:

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sinusitis; Swelling at injection site; This spontaneous case was reported by a patient and describes the occurrence of SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L204) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site). The patient was treated with LEVOTHYROXINE SODIUM (SYNTHROID) at a dose of UNK dosage form; ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) at a dose of UNK dosage form and LISINOPRIL at a dose of UNK dosage form. At the time of the report, SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1543665
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Adverse event following immunisation; This spontaneous case was reported by a patient and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (Side Effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (Side Effects). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (Side Effects) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1543666
Sex: F
Age:
State: NY

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash at injection site; itchiness at the site of reaction; Redness at site of injection; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the site of reaction), VACCINATION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE RASH (Rash at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the site of reaction) and VACCINATION SITE ERYTHEMA (Redness at site of injection). On an unknown date, the patient experienced VACCINATION SITE RASH (Rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at the site of reaction), VACCINATION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE RASH (Rash at injection site) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. As per the reported follow-up, "the rash she experienced came about 2 weeks after her first vaccine and went away after no more than 3 days as I remember." The reporter considered the patient's reaction as minor and the patient did not seek any medical attention. The patient received the second vaccine dose on an unspecified date and "had no problem." Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Updated outcomes of events to recovered/resolved, dose 2 regimen added, reporter's first name corrected, action taken updated

Other Meds:

Current Illness:

ID: 1543667
Sex: M
Age:
State: TX

Vax Date: 12/24/2020
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: he was unable to receive his second vaccine as scheduled; This spontaneous case was reported by a health care professional and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (he was unable to receive his second vaccine as scheduled) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (he was unable to receive his second vaccine as scheduled). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (he was unable to receive his second vaccine as scheduled) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2020, SARS-CoV-2 test: positive (Positive) COVID Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Treatment included Dsansone was noted. Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Lab data added were added.

Other Meds:

Current Illness:

ID: 1543668
Sex: F
Age: 69
State: MD

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feels so bad, I was in a fog; my bowels wanted to move, but wouldn't move; fluish; moaning; Shaking; throwing up all over the place; banging headache; had chills that she was shaking; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning) and TREMOR (Shaking) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M012120N) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 01-Nov-2020. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of UNK dosage form. On 22-Jan-2021, INFLUENZA LIKE ILLNESS (fluish) had resolved. At the time of the report, FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. The patient reported that she felt much better on 23 Jan 2021. Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No new significant information was provided. The reporter's email I address was updated.

Other Meds:

Current Illness:

ID: 1543669
Sex: F
Age: 34
State: VT

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant; Soreness in arm; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and VACCINATION SITE PAIN (Soreness in arm) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 013M20A) for COVID-19 vaccination. The patient's past medical history included Gestational diabetes (Maternal medical history includes gestational diabetes) in April 2017. Concurrent medical conditions included Allergy (Seasonal Allergies). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 03-Jan-2021 and the estimated date of delivery was 10-Oct-2021. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness in arm). On 04-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the first week of the pregnancy. On 14-Jan-2021, VACCINATION SITE PAIN (Soreness in arm) had resolved. On 04-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Pregnancy test: positive Positive. Patient previously had live full term child birth. The patient's estimated date of conception was 17-JAN-2021 No concomitant medications were reported. No treatment information was provided/

Other Meds:

Current Illness:

ID: 1543670
Sex: F
Age: 84
State: AZ

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diarrhea; Vomiting; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), VOMITING (Vomiting) and FATIGUE (Fatigue) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (Vomiting) and FATIGUE (Fatigue). At the time of the report, DIARRHOEA (Diarrhea), VOMITING (Vomiting) and FATIGUE (Fatigue) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No relevant concomitant medications were reported. Patient did not use any treatment medications

Other Meds:

Current Illness:

ID: 1543671
Sex: F
Age: 76
State:

Vax Date: 01/09/2021
Onset Date: 01/23/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: after two weeks her face become red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (after two weeks her face become red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (after two weeks her face become red). At the time of the report, ERYTHEMA (after two weeks her face become red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported by reporter. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1543672
Sex: F
Age: 33
State: FL

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: welt in left forearm; extreme body aches; maternal exposure during pregnancy; pain in injection site; chills; headache; muscle pain; fever; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of URTICARIA (welt in left forearm), PAIN (extreme body aches), EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy), VACCINATION SITE PAIN (pain in injection site) and CHILLS (chills) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS), FOLIC ACID (VITAFOL [FOLIC ACID]), FERROUS SULFATE (SLOW FE), GUAIFENESIN (MUCINEX) and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication. On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Jul-2020 and the estimated date of delivery was 15-Apr-2021. On 08-Feb-2021, the patient experienced URTICARIA (welt in left forearm), PAIN (extreme body aches), EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle pain) and PYREXIA (fever). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirtieth week of the pregnancy. The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 08-Feb-2021, EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved. On 09-Feb-2021, URTICARIA (welt in left forearm), PAIN (extreme body aches), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle pain) and PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE PAIN (pain in injection site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: DICLEGIS; VITAFOL [FOLIC ACID]; SLOW FE; MUCINEX; CLARITIN [LORATADINE]

Current Illness:

ID: 1543673
Sex: F
Age: 36
State:

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on the injection site about the size of a tennis balls; Itchiness; hotness/sensitive pain-touch; Redness; Head rush; Low blood pressure; Heart palpitations; Chills; Body aches; Night sweats; Extreme are soreness and arm pain; Flu like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 12-Jan-2021, the patient experienced CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain). On 13-Jan-2021, the patient experienced PALPITATIONS (Heart palpitations). On 15-Jan-2021, the patient experienced DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure). On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch) and VACCINATION SITE ERYTHEMA (Redness). On 14-Jan-2021, PALPITATIONS (Heart palpitations) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats), PAIN IN EXTREMITY (Extreme are soreness and arm pain), VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch), DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure) outcome was unknown and VACCINATION SITE ERYTHEMA (Redness) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment medications included Benadryl-one and Motrin- 2. No concomitant medications were provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm